Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

CaV2.1 (pCR3.1) Citations (2)

Originally described in: Novel CaV2.1 clone replicates many properties of Purkinje cell CaV2.1 current.
Richards KS, Swensen AM, Lipscombe D, Bommert K Eur J Neurosci. 2007 Nov . 26(10):2950-61. PubMed Journal

Articles Citing CaV2.1 (pCR3.1)

Articles
Transient Confinement of CaV2.1 Ca(2+)-Channel Splice Variants Shapes Synaptic Short-Term Plasticity. Heck J, Parutto P, Ciuraszkiewicz A, Bikbaev A, Freund R, Mitlohner J, Andres-Alonso M, Fejtova A, Holcman D, Heine M. Neuron. 2019 Jul 3;103(1):66-79.e12. doi: 10.1016/j.neuron.2019.04.030. Epub 2019 May 16. PubMed
A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs. Ojala KS, Ginebaugh SP, Wu M, Miller EW, Ortiz G, Covarrubias M, Meriney SD. J Biol Chem. 2021 Jan-Jun;296:100302. doi: 10.1016/j.jbc.2021.100302. Epub 2021 Jan 17. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.